Phase 2 HER2-expressing Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
Locally Advanced or Metastatic HER2-Expressing Cancers
Vir Biotechnology, Inc.645 enrolled10 locationsNCT05356741
Recruiting
Phase 1Phase 2
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
HER2-expressing Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.364 enrolled15 locationsNCT06015048